Although the differences in the two forms of LCN2 were not the result of glycosylation in the case of chronic myelogenous leukemia [38], our results suggest that multiple glycoforms of urinary LCN2 can be generated by changing the attached N-glycans. The gene discussed is LCN2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.